Is human T-cell lymphotropic virus type I really silent?

B Asquith, E Hanon, G P Taylor, C R Bangham, B Asquith, E Hanon, G P Taylor, C R Bangham

Abstract

The role of the cellular immune response to human T-cell lymphotropic virus type I (HTLV-I) is not fully understood. The low level of HTLV-I protein expression in peripheral blood lymphocytes has led to the widely held belief that HTLV-I is transcriptionally silent in vivo. However, most HTLV-I-infected individuals mount a strong and persistently activated cytotoxic T-lymphocyte (CTL) response to the virus; this observation implies that there is abundant chronic transcription of HTLV-I genes. Here we show that HTLV-I Tax protein expression rises quickly in freshly isolated peripheral blood lymphocytes, but that expressing cells are rapidly killed by CTLs. Mathematical analysis of these results indicates that the CTL response is extremely efficient and that the half-life of a Tax-expressing cell is less than a day. We propose that HTLV-I protein expression in circulating lymphocytes is undetectable by current techniques because of the efficiency of the CTL-mediated immune surveillance in vivo.

References

    1. J Virol. 1999 Dec;73(12):10289-95
    1. J Mol Evol. 1996 Apr;42(4):452-8
    1. J Clin Invest. 1988 Dec;82(6):1908-14
    1. Proc Natl Acad Sci U S A. 1989 Jul;86(14):5620-4
    1. J Gen Virol. 1990 Feb;71 ( Pt 2):333-41
    1. Ann Neurol. 1990 Feb;27(2):149-56
    1. Immunodefic Rev. 1988;1(1):23-38
    1. J Virol. 1990 Nov;64(11):5682-7
    1. J Virol. 1991 Mar;65(3):1628-33
    1. Immunol Today. 1991 Apr;12(4):102-5
    1. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13 Suppl 1:S92-9
    1. Clin Infect Dis. 1996 Jul;23(1):138-45
    1. Blood. 1997 May 1;89(9):3303-14
    1. J Immunol. 1997 Aug 15;159(4):2018-25
    1. Nature. 1998 Dec 17;396(6712):690-5
    1. Nat Med. 1999 Jan;5(1):83-9
    1. J Immunol. 1999 Feb 1;162(3):1765-71
    1. J Neurovirol. 1998 Dec;4(6):586-93
    1. Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3848-53
    1. Immunol Today. 1999 May;20(5):220-7
    1. J Neurovirol. 1999 Jun;5(3):241-8
    1. Proc Natl Acad Sci U S A. 1980 Dec;77(12):7415-9
    1. N Engl J Med. 1985 Jul 11;313(2):79-84
    1. Int J Cancer. 1985 Jul 15;36(1):1-7
    1. Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2110-4
    1. J Neurol Sci. 1992 Jan;107(1):98-104
    1. Virology. 1992 Dec;191(2):837-45
    1. Virology. 1993 Sep;196(1):25-33
    1. J Infect Dis. 1994 Apr;169(4):941-3
    1. J Virol. 1994 Oct;68(10):6778-81
    1. AIDS Res Hum Retroviruses. 1994 Oct;10(10):1259-68
    1. Am J Trop Med Hyg. 1995 Oct;53(4):412-8
    1. Science. 1996 Apr 5;272(5258):74-9
    1. J Immunol. 1996 May 15;156(10):3678-86
    1. Blood. 2000 Feb 15;95(4):1386-92

Source: PubMed

3
Suscribir